Baxter International (BAX) Hisse Fiyat
Baxter International Fiyat
Baxter International, son 19 yılda gelirini yıllık %0,4 artırarak 11,24 Md USD seviyesine taşıdı. Hisse başına kâr, son 17 yılda yıllık %5,5 büyüdü. Baxter International için net marj, %-8,5 ile birkaç yıl önceki %10,6 seviyesine göre geriledi. Bugünkü fiyata göre temettü verimi kabaca %2,05 seviyesine denk geliyor. Baxter International için 12 aylık konsensüs fiyat hedefi 24,50 USD; bu, hissenin bugünkü fiyatının yaklaşık %3,5 altında bir seviyeye denk geliyor. 20 analistten 5 tanesi hisse için alım öneriyor — genel konsensüs: Tut.
Baxter International hisse senedi fiyatı
Bu verilere Eulerpool API üzerinden ulaşın
Ayda 100.000 ücretsiz istek · kredi kartı yok
Baxter International iş modeli ve hisse analizi
Baxter International hakkında sık sorulan sorular
The business model of Baxter International Inc. is centered around developing, manufacturing, and marketing a broad portfolio of products and therapies for patients with life-threatening medical conditions. Baxter provides essential healthcare solutions across the clinical areas of critical care, nutrition, renal, and pharmaceuticals. The company's products and services aim to support healthcare professionals in improving patient outcomes and enhancing overall medical care. Baxter International Inc. operates globally and collaborates with various stakeholders in the healthcare industry to deliver innovative solutions that address unmet medical needs.
Baxter International Inc is primarily active in the healthcare industry. As a global leader in medical technology, Baxter specializes in providing innovative solutions for hospitals, clinics, and home care settings. The company focuses on various segments within healthcare, including renal care, acute therapies, and medication delivery. With a wide range of products and services, Baxter plays a vital role in enhancing patient care and improving outcomes across the healthcare continuum.
The main competitors of Baxter International Inc in the market include Johnson & Johnson, Fresenius Medical Care AG & Co. KGaA, and Becton, Dickinson and Company.
Baxter International Inc., based in Deerfield, Illinois, is a renowned American healthcare company with a rich history and impressive background. Established in 1931, Baxter has consistently excelled in developing and manufacturing medical products and technologies, specializing in biotherapeutics, renal care, and medication delivery. With a commitment to advancing patient care, Baxter has grown to become a global leader in the healthcare industry. Over the years, the company has introduced numerous innovative and life-saving solutions, including intravenous therapies, vaccines, and devices for dialysis. With its dedication to meeting critical healthcare needs worldwide, Baxter International Inc. continues to be a prominent player in the medical field.
Over the years, Baxter International Inc has achieved numerous significant milestones, solidifying its position in the healthcare industry. One notable achievement is the development of innovative medical products and therapies that have improved patient outcomes globally. Baxter International Inc has also demonstrated its commitment to sustainability by implementing eco-friendly practices and receiving recognition for its environmental efforts. Additionally, the company has expanded its international presence through strategic acquisitions and collaborations, further strengthening its global footprint. Overall, Baxter International Inc's dedication to innovation, sustainability, and global expansion has propelled it to become a leading player in the healthcare sector.
Baxter International Inc is primarily present in numerous countries and regions globally. This healthcare company operates in North America, including the United States, Canada, and Mexico. It has a strong presence in Europe, spanning countries like Germany, France, Italy, and the United Kingdom. Baxter International Inc also has significant operations in the Asia-Pacific region, with a focus on countries such as China, Japan, India, and Australia. Additionally, the company maintains a presence in Latin America, including Brazil, Argentina, and Chile. With its extensive global reach, Baxter International Inc serves a diverse range of markets and communities worldwide.
Baxter International Inc represents values of integrity, innovation, and collaboration. With a corporate philosophy focused on improving patient outcomes, the company strives to provide high-quality healthcare products and services worldwide. Baxter International Inc is committed to advancing medicine through its diverse portfolio of medical devices, pharmaceuticals, and biotechnology solutions. As a global leader, Baxter International Inc consistently emphasizes ethical practices, regulatory compliance, and sustainability. By actively investing in research and development, Baxter International Inc aims to drive positive changes in healthcare and enhance the well-being of patients globally.
Analistler şu anda Baxter International hissesi için ortalama 23,83 USD hedef fiyat belirliyor (medyan: 24,50 USD); bu, son fiyata göre -6,1 % anlamına gelir. Konsensüs 20 analist notuna dayanır.
20 analist şu anda Baxter International hissesini değerlendiriyor: 5 al, 14 tut, 1 sat öneriyor. 2026 için analistler Baxter International şirketinin 11,72 Md USD gelir ve 2,09 USD hisse başına kâr üretmesini bekliyor.
Güncel döviz kuruyla Baxter International hissesi 23,12 EUR (25,39 USD) seviyesindedir.
Baxter International hissesi (BAX) 11 borsada işlem görür, bunlar arasında: NYSE (BAX), London (0QK8.L), SIX (Zürich) (BAX.SW), XETRA (BTL.DE), Frankfurt (BTL.F), München (BTL.MU), Düsseldorf (BTL.DU), Hamburg (BTL.HM).
Baxter International Inc is a US-based company operating in the healthcare and pharmaceutical sectors. The company provides medical products and services to supply patients worldwide. It is divided into three main business segments: Hospital Products, Renal Products, and Clinical Nutrition. Hospital Products is the largest segment and offers a variety of products including infusion solutions, injectables, medical devices, and concentrated solutions. Renal Products includes products and services for dialysis treatment, home hemodialysis, and acute kidney failure. Baxter also manufactures dialysis machines and accessories, as well as dialysis containers and concentrates. Clinical Nutrition also offers specialized nutrition products and preparations for parenteral nutrition. The company is a leading provider of parenteral nutrition products, including amino acids, carbohydrates, fat emulsions, and electrolytes. Baxter International also manufactures blood products such as plasma products and clotting factors. Additionally, the company offers specially processed biological products that can be used to treat conditions such as hemophilia and immunodeficiency. The company also operates an advanced life sciences business focused on drug development and medical devices. Baxter International collaborates with numerous global partners and develops innovative technologies in oncology and other areas of medical research. Baxter International is a company focused on proactive solutions to improve patient care and provide safe, effective, and high-quality medical products. The company is also committed to sustainable development and environmental protection by optimizing its materials and energy sources and continuously improving its production technology. In summary, Baxter International is a company dedicated to the development and provision of high-quality medical products and services. Through its various business segments, the company offers a wide range of products and services for different medical conditions to improve the medical care of patients worldwide. The company has also committed to sustainable and environmentally friendly production to fulfill its responsibility to society and the environment.
beklenen'nin Baxter International hasılatı 11,72 Md USD'dir. Bu rakam, mevcut finansal verilere dayanmakta ve şirketin iş performansını yansıtmaktadır.
beklenen'nin Baxter International karı 1,07 Md USD'dir. Net kar, tüm giderleri düştükten sonra şirketin kârlılığını gösterir.
Baxter International'nin Fiyat/Kazanç (F/K) oranı şu anda 12,15'dir. F/K oranı, cari hisse fiyatını hisse başına kazançla karşılaştırır ve yatırımcıların Baxter International hisse senedinin değerlemesini değerlendirmelerine yardımcı olur.
Baxter International'nin Fiyat/Satış (F/S) oranı şu anda 1,11'dir. F/S oranı, pazar kapitalizasyonunu yıllık gelirle karşılaştırır ve Baxter International hisse senedinin değerleme metriği olarak hizmet eder.
Baxter International'nin Eulerpool Kalite Puanı 1/10'dur.
Baxter International'nin ISIN'i US0718131099'dir. ISIN (Uluslararası Menkul Kıymetler Kimlik Numarası), menkul kıymetler için küresel olarak benzersiz bir tanımlayıcıdır.
Baxter International'nin WKN'i 853815'dir. WKN (Wertpapierkennnummer), menkul kıymetleri tanımlamak için kullanılan altı haneli bir Alman kimlik numarasıdır.
Baxter International'nin ticker'ı BAX'dir. Ticker sembolü, Baxter International hisseleri borsada işlem görmek için kullanılır.
Baxter International Hissesi
Baxter International Emsaller Grubu
Baxter International Ticker
Baxter International FIGI
Baxter International'nin tüm temel göstergeleri ve derinlemesine analizi
Baxter International hissesine yönelik aktienanalizimiz, satış, kar, P/E oranı, P/S oranı, EBIT gibi önemli mali kriterleri içermekte olup, dividende bilgilerini de ele almaktadır. Ayrıca, hisseler, piyasa değeri, borçlar, özsermaye ve Baxter International şirketin yükümlülükleri gibi konuları incelemekteyiz. Bu konular hakkında daha detaylı bilgilere ihtiyacınız varsa, web sitemizin alt sayfalarında kapsamlı analizler sunuyoruz: